Inogen (INGN) Long-Term Deferred Tax (2013 - 2024)
Inogen's (INGN) quarterly Long-Term Deferred Tax came in at $75.7 million in Q4 2024, up 83.86% year-on-year from $41.2 million in Q1 2024, and up 83.86% on a QoQ basis from $41.2 million in Q4 2023.
Inogen (INGN) Long-Term Deferred Tax (2013 - 2024) Analysis & Trends
Inogen (INGN) has 12 years of Long-Term Deferred Tax data on file, last reported at $75.7 million in Q4 2024.
- On a quarterly basis, Long-Term Deferred Tax rose 83.86% year-over-year to $75.7 million in Q4 2024; TTM through Dec 2024 was $75.7 million, a 83.86% increase from a year earlier, with the FY2024 full-year figure at $75.7 million, up 83.86% from the prior year.
- Long-Term Deferred Tax for Q4 2024 stood at $75.7 million, up from $41.2 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for INGN reached as high as $75.7 million in Q4 2024 and fell as low as $9.2 million in Q2 2021.
- Historically, Long-Term Deferred Tax has averaged $28.5 million across 5 years, with a median of $15.5 million in 2021.
- Across the five-year window, Long-Term Deferred Tax sank 49.99% in 2020 and surged 83.86% in 2024, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $14.5 million in 2020, then rose by 7.01% to $15.5 million in 2021, then jumped by 260.98% to $55.9 million in 2022, then decreased by 26.28% to $41.2 million in 2023, then jumped by 83.86% to $75.7 million in 2024.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $75.7 million in Q4 2024, $41.2 million in Q4 2023, and $55.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 75.74 Mn |
| Dec 31, 2023 | 41.20 Mn |
| Dec 31, 2022 | 55.88 Mn |
| Sep 30, 2021 | 15.48 Mn |
| Jun 30, 2021 | 9.17 Mn |
| Mar 31, 2021 | 15.99 Mn |
| Dec 31, 2020 | 14.47 Mn |
| Sep 30, 2020 | 14.08 Mn |
| Mar 31, 2020 | 14.65 Mn |
| Dec 31, 2019 | 14.45 Mn |
| Sep 30, 2019 | 11.18 Mn |
| Jun 30, 2019 | 26.06 Mn |
| Mar 31, 2019 | 29.30 Mn |
| Dec 31, 2018 | 30.13 Mn |
| Sep 30, 2018 | 26.28 Mn |
| Jun 30, 2018 | 20.74 Mn |
| Mar 31, 2018 | 20.43 Mn |
| Dec 31, 2017 | 18.64 Mn |
| Sep 30, 2017 | 24.62 Mn |
| Jun 30, 2017 | 25.99 Mn |